Introduction
It is now widely accepted that nitric oxide (NO) synthesized from -arginine is the substance that accounts for the activity originally described by Furchgott and Zawadzki as 'endothelium-derived relaxing factor'. Nitric oxide is produced by virtually all mammalian cells. In the intestine, nitric oxide is produced by three distinct enzyme systems, referred to as nitric oxide synthases (NOS). A neurally associated, constitutive form of NOS found in neurons of the enteric nervous system is referred to as NOS1 or ncNOS. An inducible form of the enzyme, referred to as NOS2 or iNOS, is found under appropriate circumstances in endothelial cells, the epithelium and in a number of immunocytes. This enzyme can be induced by exposure to various cytokines and endotoxin. NOS3 (or ecNOS) is a constitutively expressed enzyme found primarily in the endothelium lining blood vessels, but may also exist in intestinal epithelial cells and mast cells. One of the important distinguishing features between the constitutive and inducible forms of NOS is the calcium-dependency of the former but not the latter. For the most part, NOS1 and NOS3 can be regarded as the forms that are responsible for producing nitric oxide in a physiological context, whereas NOS2 produces nitric oxide in pathophysiological circumstances. However, this statement should not be construed as meaning nitric oxide derived from NOS2 only acts in a detrimental manner.
In recent years, a plethora of studies have implicated NO as a critical mediator of mucosal defence in the gastrointestinal tract. On the other hand, it has been suggested by many groups that nitric oxide contributes to mucosal injury in several human gastrointestinal disorders and in experimental animal models of gastrointestinal injury. Like oxygen, high concentrations of NO oxide are cytotoxic. While there are considerable data suggesting that NO production is greatly elevated in situations of mucosal inflammation, such as in inflammatory bowel disease, it has yet to be clearly established that NO plays a primarily damaging role in those circumstances, or that it ever accumulates to concentrations that could achieve such results.
In this review, we summarize some of the key evidence suggesting a role for nitric oxide in the maintenance of gastrointestinal mucosal integrity, and we challenge the hypothesis that nitric oxide, when present in 'large' amounts, necessarily results in mucosal injury and dysfunction.
Nitric oxide and mucosal defence
The mucosa of the gastrointestinal tract is continuously exposed to potentially damaging substances, such as acid, digestive enzymes, bacterial toxins and bile. The ability of the mucosa of the gastrointestinal tract to resist injury by these sub- (C) superoxide and associated oxidants including into autoperfused segments of cat ileum. 7 Rather hydrogen peroxide. Thus, in addition to prevent-than looking for overt tissue damage, very subtle ing leukocyte adhesion and infiltration into the functional alterations were used as indices of reperfused intestine, nitric oxide may also intestinal dysfunction. These included measuredirectly affect the cytotoxicity of neutrophils by ments of both microvascular and mucosal peraltering the ability of this cell to produce oxi-meability. These studies clearly demonstrated that dants. Other inhibitory effects of nitric oxide local infusion of compounds that would release donors on neutrophil function have also been 'large' amounts of NO failed to cause changes in reported. 59- microvascular permeability, changes in the integrity of the mucosal barrier or impairment in the Nitric oxide is an anti-oxidant functional aspects (absorption or secretion) of the small bowel. Furthermore, when these NO In addition to being anti-adhesive, nitric oxide donors were added to endothelial or epithelial has the capacity to inhibit reactive oxygen metacells in vitro, they failed to produce detectable bolites, including superoxide anion, and can damage. This is in sharp contrast to the proprevent the cellular damage attributable to found injury (i.e. lysis) observed when a hypoxhydrogen peroxide. 2 
